as one of the most metabolically demanding organs, the heart has the highest NAD + levels
When compared to those taking topiramate, GLP-1 users were: 48% less likely to start valproate 42% less likely to start calcitonin gene-related peptide (CGRP) monoclonal antibodies 35% less likely to start tricyclic antidepressants 23% less likely to start the class of drugs called gepants However, there was no significant difference between the two groups, and the need to begin taking beta-blockers
The side effect profile mirrors what you'd expect from GLP-1-based drugs: Nausea, particularly when starting or increasing the dose Diarrhoea and, less often, constipation Reduced appetite (which is, of course, partly the point) Tiredness in the first few weeks Occasional vomiting at higher doses In the Phase 2 trials, most side effects were rated mild to moderate and tended to settle as the body adjusted
What is the #1 substance studied for gut repair in research
Drugs that block the action of DPP-4 are called DPP-4 inhibitors and these have been used in the treatment of type 2 diabetes for many years